Trial Profile
A RANDOMIZED, OPEN COMPARISON BETWEEN PREGABALIN/TRANSDERMAL BUPRENORPHINE AND PREGABALIN/DICLOFENAC IN CHRONIC NEUROPATHIC PAIN PATIENTS.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary) ; Pregabalin (Primary) ; Diclofenac
- Indications Neuropathic pain
- Focus Adverse reactions; Therapeutic Use
- 04 Aug 2011 New trial record